InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (3 ops.)
Insider track record
CFODisclosed buys
0
Disclosed sells
3
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the full record of transactions filed by Schorno Dean L, Chief Financial Officer. Officer active across 1 company, notably RIGEL PHARMACEUTICALS INC. In total, 16 filings have been published. Split: 0 buy · 3 sells. Total volume traded: €55k. History available since 24 January 2022. The latest transaction was filed on 1 September 2026 (Retenue fiscale). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Schorno Dean L
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations16 total
928 shares@ US$47.50Common StockSEC:0000905148-26-004080:0
694 shares@ US$12.70Common StockSEC:0000905148-26-004080:1
620 shares@ US$18.70Common StockSEC:0000905148-26-004080:2
2,000 shares@ US$24.20Common StockSEC:0000905148-26-004080:3
1,286 shares@ US$24.20Common StockSEC:0000905148-26-004080:4
20,636 shares0Common StockSEC:0000905148-26-000952:0
3,546 shares@ US$34.6228.7% of flowCommon StockSEC:0000905148-26-000678:0
5,488 shares@ US$36.0146.5% of flowCommon StockSEC:0000905148-26-000497:0
1,987 shares@ US$20.0038.1% of flowCommon StockSEC:0000905148-25-004492:0
2,036 shares@ US$20.92174.7% of flowCommon StockSEC:0000905148-25-000413:0
19,717 shares0Common StockSEC:0000905148-25-000300:0
5,601 shares@ US$1.129610.5% of flowCommon StockSEC:0000905148-24-000446:0
209,000 shares0Common StockSEC:0000905148-24-000306:0
5,389 shares@ US$1.660114.7% of flowCommon StockSEC:0001140361-23-004732:0
63,000 shares0Common StockSEC:0001140361-23-003441:0
50,000 shares0Common StockSEC:0001567619-22-001782:0
16 of 16 declarations
About Schorno Dean L
Schorno Dean L is Directeur Financier and EVP & Chief Financial Officer at RIGEL PHARMACEUTICALS INC. He has 11 filings in total, and across the 11 sampled filings, the sell amount is EUR 55186, with activity ranging from 2022-01-26 to 2026-02-19; the modal transaction nature is Attribution.
